Description
Fluorescent Human CD20 Full Length Protein (VLP) | CDP-HF2P8-20ug| Gentaur Distribution US, UK & Europe
B-lymphocyte antigen CD20 is also known as B-lymphocyte surface antigen B1, Leukocyte surface antigen Leu-16, Membrane-spanning 4-domains subfamily A member 1 and MS4A1, is an activated-glycosylated phosphoprotein expressed on the surface of all B-cells beginning at the pro-B phase (CD45R+, CD117+) and progressively increasing in concentration until maturity. CD20 is expressed on all stages of B cell development except the first and last; it is present from late pro-B cells through memory cells, but not on either early pro-B cells or plasma blasts and plasma cells. It is found on B-cell lymphomas, hairy cell leukemia, B-cell chronic lymphocytic leukemia, and melanoma cancer stem cells. The protein has no known natural ligand and its function is to enable optimal B-cell immune response, specifically against T-independent antigens. It is suspected that it acts as a calcium channel in the cell membrane. CD20 / MS4A1 is the target of the monoclonal antibodies (mAb) rituximab, Ibritumomab tiuxetan, and tositumomab, which are all active agents in the treatment of all B cell lymphomas and leukemias. Defects in CD20 / MS4A1 are the cause of immunodeficiency common variable type 5 (CVID5) ; also called antibody deficiency due to CD20 defect. CVID5 is a primary immunodeficiency characterized by antibody deficiency, hypogammaglobulinemia, recurrent bacterial infections and an inability to mount an antibody response to antigen.
Source: Fluorescent Human CD20 Full Length Protein-VLP (CDP-HF2P8) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Pro 297 (Accession # NP_068769.2).
Format: Liquid.
Tag: GFP Tag.
Expression System: HEK293.
Expression Region: Met 1 - Pro 297.
Conjugate: GFP Fusion.
Molecular Weight: N/A.
Characteristics: This protein carries a GFP tag.
Purity: N/A.
Buffer: PBS, pH7.4.
Storage Conditions: -70℃, aviod light.
Shipping Conditions: Dry ice
